Federal Focus Shifts to COVID-19 Treatments
FDA releases guidance on using blood from recovered COVID-19 patients to treat new cases.
COVID-19 and Cooperative Administrative Federalism in Germany
Germany’s response to COVID-19 consists of federal delegation, state regulation, and multi-level cooperation.
Learning in the Age of Social Distancing
An Education Department proposal paves the way for a new normal in online instruction.
Continuous Judicial Review in Coronavirus Times
The Israeli judiciary exerts oversight and influence over the executive’s COVID-19 response.
The Match Between COVID-19 and Plastic Bans
The COVID-19 pandemic tests the strength of U.S. bans on single-use plastic products.
GDPR and Artificial Intelligence
Europe’s General Data Protection Regulation could impact AI startups that depend heavily on data.
Week in Review
FDA issues heightened standards for antibody tests, the Department of Justice announces first arrests for COVID-19 emergency lending fraud, and more…
Rescuing the European Economy from COVID-19
Political and constitutional constraints hinder the EU’s response to the economic crisis.
Regulating in Times of Tragic Choices
As Italy begins its second phase of COVID-19 regulation, trust in government regulatory action is essential.
Calls for Regulatory Approval of Edible Insects
Edible insects may become essential in the wake of the COVID-19 crisis, but FDA regulation is lacking.
Rethinking Judicial Oversight in a Time of Crisis
Administrative accountability demands resilient courts, especially in emergencies.
Your COVID-19 Immunity Papers, Please
Coronavirus immunity certificates could permit recovered persons to escape lockdown restrictions.